- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
PMCPA case AUTH/3072/9/18 (Director v Servier) concerned clinical trial disclosure but was ruled outwith the scope of the…
MSD challenged a Victoza detail aid using a “triple composite endpoint” shown in prominent red boxes. PMCPA ruled…
Allergan was ruled in breach after a meeting presentation and representative conduct implied Vistabel/Botox was more potent than…
ViiV admitted a February 2015 journal issue carried a 2-page Triumeq ad plus a belly band wrap, exceeding…
Baxter admitted a representative did not take all required ABPI representative exam modules within 12 months of starting.…
A nurse complained about a Remsima switch email. PMCPA found an exaggerated UK-wide “re-investing savings” claim was misleading/unsubstantiated…
Anonymous complaints alleged inappropriate hospitality and a “nexus” with organisers at a schizophrenia meeting sponsored by Otsuka and…
Bayer admitted a leaflet that should have been withdrawn under an undertaking was still displayed at BAUS. PMCPA…
Anonymous complaint about a meeting advertised on LinkedIn. PMCPA concluded no breach because the matter was outwith the…
GSK’s HCP webinar registration page about fluticasone furoate was deemed promotional for Relvar Ellipta but omitted prescribing information.…
One real case. One key lesson. Every week — free.